SCHEMBL515763

SCHEMBL515763

CCC1CCc2nc(N3CCN(c4nc5c(c(N[C@@H](CO)C(C)C)n4)[S+]([O-])CC5)CC3)cnc2CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10193228 0.84 HSP90AA1 (0.33) —
SCHEMBL7713979 0.84 HSP90AA1 (0.33) —
SCHEMBL515783 0.79 ABL1 (0.33) —
Trifluoroacetic Acid SCHEMBL17019859 0.78 HSP90AA1 (0.32) —
SCHEMBL18683880 0.77 SORD (0.39) —
SCHEMBL516214 0.77 SORD (0.39) —
SCHEMBL194785 0.75 PANK3 (0.38) —
SCHEMBL7709089 0.75 PANK3 (0.38) —
SCHEMBL10266618 0.75 AXL (0.30) —
SCHEMBL7715595 0.74 CCNA2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028932-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-02 — — US claimed
US-20120028932-A1 DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-02 — — US disclosed
Send feedback